Drug Price Cut Paves Way in Global Fight Against Tuberculosis

The price of rifapentine, a lifesaving antibiotic that can prevent tuberculosis, was marked down by 66% by its manufacturer Sanofi, an announcement Gavin Churchyard for The Conversation Africa describes as good news. Talks to lower the price from U.S.$45 to U.S.$15 for a three-month course took more than a year to complete with an announcemnt eventually made during the Union World Conference on Lung Health in October 2019.

(file photo).


See What Everyone is Watching

Don't Miss

AllAfrica publishes around 800 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.